Navigation Links
Many Breast Cancer Patients in Their 40s Aren't 'High-Risk': Study
Date:5/3/2012

By Kathleen Doheny
HealthDay Reporter

THURSDAY, May 3 (HealthDay News) -- More than half of women in their 40s diagnosed with breast cancer after a routine mammogram had no family history of the disease, finds a new study that may add to the debate over the timing of breast cancer screening.

The researchers say their results point to the value of annual screening mammograms for women 40 to 49. But others remain unconvinced.

Family history usually means a first-degree relative with the disease (parent, sibling or child). Of those without family history who were found to have breast cancer, "64 percent of these women had invasive disease," said researcher Dr. Stamatia Destounis, a radiologist at Elizabeth Wende Breast Care Center and a clinical associate professor at the University of Rochester in New York.

Destounis was to present her findings at the American Roentgen Ray Society annual meeting in Vancouver on Thursday.

This is one of numerous studies undertaken to determine the ideal age for women to begin screening mammograms and the appropriate intervals between screenings. In 2009, the U.S. Preventive Services Task Force (USPSTF) sparked controversy when it recommended screening mammograms every two years for women aged 50 to 74, but not younger.

The USPSTF advised women 40 to 49 at average risk of breast cancer to discuss the pros and cons with their doctors and then decide about the value of screening. That was because the task force found a small benefit for the younger women and moderate harm, such as false positive results.

However, the American Cancer Society and other organizations continue to recommend annual screening beginning at age 40.

Earlier this week, an analysis published in the Annals of Internal Medicine concluded that women in their 40s who have a family history of breast cancer or extremely dense breasts should consider getting a mammogram every two years. The researchers said that for those women the benefits of screening every two years outweigh the risks.

In the new study, Destounis and her colleagues evaluated records of all mammograms conducted at the imaging center from 2000 to 2010. They focused on 373 women in their 40s diagnosed with breast cancer after a routine mammogram. Of these, 228 -- or 61 percent -- had no family history of the disease. Seventeen were excluded because of a personal history of cancer or other high-risk status.

Of the 211 women remaining, nearly 64 percent had invasive disease, and 15 percent had cancer cells in their lymph nodes.

"This study reinforces the importance of screening mammography in the 40-to-49 age group with no family history as a risk factor," Destounis concluded.

However, the chair of the USPSTF said the study does not prove that the cancers were detected because of the mammograms.

"The assumption is made that these women did better because invasive cancers were found by screening," said Dr. Virginia Moyer, also a professor of pediatrics at Baylor College of Medicine in Houston. "The only way to know that is to randomize [women] to screening or not." That would mean assigning one group of women to screening and another to no screening.

Those are the kinds of studies the task force looked at when producing the 2009 guidelines, Moyer said. The USPSTF found a small benefit for women in their 40s balanced by a moderate risk of harms, she said.

"Their data only shows they found invasive cancer, not that the women benefited directly from the mammogram," Moyer added.

Data and conclusions of research presented at medical meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

To learn more about mammograms, visit the American Cancer Society.

SOURCES: Stamatia Destounis, M.D., radiologist, Elizabeth Wende Breast Care Center and clinical associate professor, University of Rochester, N.Y.; American Roentgen Ray Society annual meeting, April 29-May 4, 2012, Vancouver, Canada; Virginia Moyer, M.D., M.P.H., chair, U.S. Preventive Services Task Force, and professor of pediatrics, Baylor College of Medicine, Houston


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Breast Cancer Patients in Their 40s Aren't 'High-Risk': Study
(Date:5/24/2016)... ... 24, 2016 , ... BTC Media, a leading digital currency ... to be held in Nashville, Tennessee on September 7, 2016. , The conference ... the event will host teams from around the world, competing to build the ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... debuted a new corporate identity and website at its “Transforming Outcomes” User Conference ... other marketing enhancements reflect i2i’s ongoing success to set the market standard for ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... at Sentara Northern Virginia Medical Center located in Woodbridge, VA. The project ... services into a single site. , The new 2 story building houses the ...
(Date:5/24/2016)... , ... (PRWEB) May ... three new members of its Advisory Board. Joining the Grow ... Kusch. “All three of them embody the mission of our organization ... very fortunate to have them as we continue to expand our ...
(Date:5/24/2016)... ... May 24, 2016 , ... A newly released report reveals that ... access to trusted resources, both in face-to-face interactions and online. In “Heard, Not Judged ... concluded that the creative use of mobile digital devices can be an effective tool ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016 Een app die artsen ... collectief patiënten kunnen behandelen, hun kennis kunnen delen en ... de nieuwe en revolutionaire MDLinking App, ontwikkeld door een ... dr. Hans Flu en oncologisch chirurg dr. Gijs ... is, wordt op dinsdag 24 mei officieel gepresenteerd op ...
(Date:5/23/2016)... 23, 2016 According to ... Development, Growth and Demand Forecast to 2022 - ... by Application (Drug Discovery and Development, Proteomics, Clinical ... Life Science and Biotechnology, Academic and Research Institute, ... the global mass spectrometry market was ...
(Date:5/23/2016)... , May 23, 2016 Gamida ... the treatment of cancer and orphan genetic diseases, announced ... to $4.4 million from the Israel Innovation Authority (formerly ... Ministry of Economy and Industry. The mission of the ... in various industries, including science and technology, while stimulating ...
Breaking Medicine Technology: